Subscribe To
Moderna may be facing its toughest moment ever. time to sell?
Moderna reported a billion-dollar loss in the third quarter and began downsizing its manufacturing infrastructure to match lower levels of v...
November 4, 2023, 5:00 am
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer v...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer v...
November 3, 2023, 8:30 pm
Moderna ceo discusses earnings and how the company aims to break even by 2026
While boasting a third-quarter revenue beat, biotech firm Moderna (MRNA) reported an overwhelmingly higher-than-expected loss of $9.53 per share. Its ...
November 2, 2023, 6:24 pm
Moderna shares slide after posting a loss on falling covid-19 vaccine sales and production
Moderna (MRNA) shares tumbled over 6% Thursday after reporting a steep loss as the drug maker lost sales and cut back on making its COVID-19 v...
November 2, 2023, 4:55 pm
Ocugen to host conference call on thursday, november 9 at 8:30 a.m. et to discuss business updates and third quarter 2023 financial results
MALVERN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...
November 2, 2023, 11:30 am
Moderna stock plummets on 3q loss and weak sales guidance
Moderna Therapeutics Inc (NASDAQ:MRNA) stock moved lower on Thursday after the drugmaker's weak full-year sales forecast and a significant loss for th...
November 2, 2023, 11:27 am
Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023
GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based v...
November 2, 2023, 9:25 am
Moderna revenue tops expectations, expects to return to sales growth in 2025
Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weaker demand for COVID-19 v...
November 2, 2023, 6:35 am
Hillevax to present at upcoming investor conferences
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerci...
November 1, 2023, 4:48 pm
Gsk beats on q3 earnings and sales, raises 2023 guidance
GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The com...
November 1, 2023, 12:47 pm
Gsk receives a mixed city reaction despite raised outlook
GSK PLC (LSE:GSK, NYSE:GSK) has received mixed reactions from City analysts despite an objectively strong third-quarter performance and raised financi...
November 1, 2023, 12:03 pm
Gsk boosts profit forecasts after ‘outstanding' rsv vaccine launch
High demand for the vaccine pulled in around $850 million during the third quarter—reportedly double ...
November 1, 2023, 6:38 am
Unlike pfizer, moderna can meet 2023 covid forecast, analysts say
Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID v...
November 1, 2023, 6:03 am
Wework shares plunge on report of looming bankruptcy as match group stock slumps on tinder owner's israel warning
Novovax Inc. NVAX shares jumped 3% after the U.S. pharma firm's new COVID vaccine gained approval in th...
November 1, 2023, 5:34 am
Scancell melanoma trial data chosen for poster presentation at sitc
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) told investors that it has been selected for a poster presentation of data from the first stage of its Pha...
November 1, 2023, 4:16 am
Gsk raises outlook amid strong demand for new rsv vaccine
GSK PLC (LSE:GSK, NYSE:GSK) said a strong third quarter performance has driven a further upgrade to full-year guidance boosted by demand for its respi...
November 1, 2023, 3:31 am
Gsk raises annual forecasts again on strong arexvy launch
GSK raised its full-year profit and sales forecasts on Wednesday for the second time this year, betting on the strong launch of its respiratory syncyt...
November 1, 2023, 3:05 am
Pfizer quarterly results hit by soft demand for covid-19 products
Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with...
October 31, 2023, 8:20 pm
Gsk reports earnings wednesday. what to watch.
The company will for the first time report sales of Arexvy, its new RSV vaccine that launched this fall...
October 31, 2023, 5:00 pm